Apolipoprotein e genotype has no effect on the free intracellular Ca2+ concentration of platelets from Alzheimer's disease patients

International Journal of Molecular Medicine

Volumn 3, Issue 4, 1999, Pages 431-434

  Fernandes, M A S ^a   Proenca, M T ^b   Nogueira, A J A ^c   Oliveira, L M V ^a   Santiago, B ^d   Santana, I ^a   Oliveira, C R ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Apo E genotype; Intracellular calcium homeostasis; Platelets

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; THROMBIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; THROMBOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BLOOD PLATELETS; CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; THROMBIN;

EID: 0033109294     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.4.431     Document Type: Article

References (28)

1. Lendon CL, Ashall F and Goate AM: Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277: 825-831, 1997.
2. Rebec GW: Potential biological mechanisms of Apo E in Alzheimer's disease. In: Molecular Mechanisms of Dementia. Wasco W and Tanzi RE (eds). Humana Press Inc, Totowa NJ pp 21-37, 1997.
3. 2+-channel. Brain Pathol 8: 641-653, 1998.
4. Connolly GP: Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol Sci 19: 171-177, 1998.
5. Gasparini L, Racchi M, Binetti G, Trabucchi.M, Solerte SB, Alkon D, Etcheberrigaray R, Gibson G, Blass J, Paoletti R and Govoni S: Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J 12: 17-34, 1998.
6. Hajimohammadreza I, Brammer MJ, Bagger S, Burns A and Levy R: Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochem Biophys Acta 1025: 208-214, 1990.
7. Hajimohammadreza I, Brammer MJ and Levy R: Abnormal calcium homeostasis in platelets isolated from Alzheimer's disease patients. Neurobiol Aging 11: 335-336, 1991.
8. Le Quan Sang KH, Mignot E, Gilbert JC, Huguet R, Aquino JP, Regnier O and Devynck A: Platelet cytosolic free calcium concentration is increased in aging and Alzheimer's disease. Biol Psychiatry 33: 391-393, 1993.
9. Davies TA, Fine RE, Johnson RJ, Levesque CA, Rathbun WH, Seetoo KF, Smith SJ, Strohmeier G, Volicer L, Delva L and Simons E R: Non-aged related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun 194: 537-543, 1993.
10. Davies TA, Long HJ, Rathbun WH, Sgro KR, Tibbies H, Smith SJ, Seetoo KF, McMenamin ME, Johnson R, Wells JM, Levesque C, Fine RE and Simons ER: Platelets from patients with Alzheimer's disease or other dementias exhibit disease-specific and apolipoprotein E correctable defects. Amyloid Int J Exp Clin Invest 3: 13-19, 1996.
11. Davies TA, Long HJ, Sgro KR, Rathbun WH, McMenamin ME, Seetoo KF, Tibbies H, Billingslea AM, Fine RE, Fishman JB, Levesque CA, Smith SJ, Wells JM and Simons ER: Activated Alzheimer's disease platelets retain more beta amyloid precursor protein. Neurobiol Aging 18: 147-153, 1997.
12. Davies TA, Long HJ, Tibbies HE, Sgro KR, Wells JM, Rathbun WH, Seetoo KF, McMenamin ME, Smith SJ, Feldman RG, Levesque CA, Fine RE and Simons ER: Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol Aging 18: 155-162, 1997.
13. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition (revised). APA, Washington, 1994.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D and Stadlan EM: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ARDA work Group under the auspices of Departement of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944, 1984.
15. Folstein M, Folstein S and McHugh P: Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975.
16. Hughes CP, Berg L, Danzinger W, Coben LA and Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572, 1982.
17. Berg L: Clinical dementia rating (CDR). Psychopharmacol Bull 24: 637-639, 1988.
18. Treco DA: Preparation of genomic DNA. In: Current Protocols in Molecular Biology. Ausubel FM, Breut R, Kingston RE, Moore DD, Seideman JG, Smith JA and Struh K (eds). Greene Publishing Associates and Wiley-Interscience, New York pp211-217, 1992.
19. Crook R, Hardy J and Duff K: Single-day apolipoprotein E gcnotyping. J Neurosci Methods 53: 125-127, 1994.
20. + antiporter. Med Sci Res 18: 567-568, 1990.
21. 2+] and pH in human platelets: cytoplasmic alkalinization is not a prerequisite for calcium mobilization. Biochim Biophys Acta 938: 497-500, 1988.
22. i increase during oxidative stress. Brain Res 713: 269-277, 1996.
23. Page CP: Platelet activation. J Lipid Mediat 4: 1-4, 1991.
24. Rink TJ and Hallam TJ: What turns platelets on? Trends Biochem Sci 9: 215-219, 1984.
25. Zucker MJ and Nachmias VT: Platelet activation. Arteriosclerosis 5: 2-8, 1985.
26. Scharff O and Foder B: Regulation of cytosolic calcium in blood cells. Physiol Rev 73: 547-582, 1993.
27. Hölscher C: Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis. Neurobiol Aging 5: 129-141, 1998.
28. 3). Int J Mol Med 1: 91-93 1998.